* Neuronetics Inc STIM.OQ STIM.O is expected to show a
rise in
quarterly revenue when it reports results on August 12 for the
period ending June 30 2024
* The Malvern Pennsylvania-based company is expected to
report a
5.9% increase in revenue to $18.648 million from $17.61 million
a year ago, according to the mean estimate from 4 analysts,
based on LSEG data.The company's guidance on May 7 2024, for the
period ended June 30, was for revenue between $18.00 million and
$19.00 million.
* LSEG's mean analyst estimate for Neuronetics Inc is for a
loss
of 27 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Neuronetics
Inc
is $7.00, above its last closing price of $1.87.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Mar. 31 2024 -0.32 -0.31 -0.27 Beat 12.9
Jan. 1 2024 -0.26 -0.26 -0.19 Beat 27.3
Sep. 30 2023 -0.31 -0.31 -0.33 Missed -6.7
Jun. 30 2023 -0.35 -0.35 -0.17 Beat 51.2
Jan. -0.39 -0.39 -0.38 Beat 2.1
1 0001
Dec. 31 2022 -0.35 -0.38 -0.30 Beat 21.3
Sep. 30 2022 -0.42 -0.42 -0.28 Beat 33.5
Jun. 30 2022 -0.41 -0.41 -0.39 Beat 5.3
This summary was machine generated August 9 at 18:52 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)